Chinese Children Cancer Group Relapsed Acute Lymphoblastic Leukemia 2017 Study
Latest Information Update: 31 Aug 2023
At a glance
- Drugs Bortezomib (Primary) ; Rituximab (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
Most Recent Events
- 29 Aug 2023 Status changed from recruiting to completed.
- 17 Jan 2020 New trial record